Long-Term Efficacy and Safety of a JAKi in RA How might long-term efficacy and safety data from a study of a JAKi in TNFi-IR patients with RA influence clinical decision making? Watch Dr. Stan Cohen discuss. Sponsored by AbbVie US Medical Affairs https://t.co/mvVtlMJTc2 https://t.co/YJX3nymDuU